A phase 3 study of the new Epatilon BMS247550+capesitabine in patients with advanced breast cancer previously treated with an anthracycline or taxane. Prot no: CA163048. Coordination center: Hacettepe Medical Faculty. Responsible coordinator: Prof. Dr. Esmen Baltaci. Co-investigator: Dr. Duygu Derin
A phase 3 randomized placebo-controlled double-blind study comparing oral CCI-779 in combination with letrozole versus letrozole alone in first-line hormone therapy in postmenopausal women with locally advanced or metastatic breast carcinoma. Prot no: 3066A1-303WW. Coordination center: Istanbul University Oncology Institute. Responsible coordinator: Prof.Dr. Pınar Saip. Co-investigator: Dr. Duygu Derin
Publications
Soydinc, H.O., Duranyildiz, D., Guney, N., Derin, D., Yasasever, V. ”Utility of serum and urine uPAR levels for diagnosis of breast cancer. Asian Pac J Cancer Prev. 2012;13(6):2887-9.
Vural, B., Yakar, F., Derin, D., Saip, P., Yakar, A., Demirkan, A., Karabulut, A., Ugurel, E., Cine, N., Kilicaslan, Z., Tüzün, E., Ozbek, U. ”Küçük hücreli akciğer kanserli hastalarda glutatyon S-transferaz P1 polimorfizmlerinin (Ile105Val ve Ala114Val) değerlendirilmesi. Genet Test Mol Biomarkers. 2012 Jul;16(7):701-6. doi: 10.1089/gtmb.2011.0315. Epub 2012 Feb 17.
Saip, R., Sen, F., Vural, B., Ugurel, E., Demirkan, A., Derin, D., Eralp, Y., Camlica, H., Ustuner, Z., Ozbek, U. ”Glutathione S-transferase P1 polymorphisms are associated with time to tumor progression in small cell lung cancer patients. J BUON. 2011 Apr-Jun;16(2):241-6.
Ozluk, Y., Kilicaslan, I., Kazancioglu, R., Demirkesen, C., Derin, D., Mandel, N.M. ”Intraglomerular crescentic metastases of malignant melanoma. Hum Pathol. 2011 Dec;42(12):2025-8. doi: 10.1016/j.humpath.2010.05.032. Epub 2011 Jun 12.
Beyazıt, H., Aydın, O., Demirkesen, C., Derin, D., Süt, P., Emre, A., Mandel,N. ”Gastrik adenokarsinom seyri sırasında pankreas tutulumunun ilk belirtisi olarak pankreatik pannikülit” Med Oncol. 2011 Mar;28(1):137-9. doi: 10.1007/s12032-010-9420-8. Epub 2010 Jan 30.
Bitisik, O., Saip, P., Saglam, S., Derin, D., Dalay, N. ”Mammaglobin and maspin transcripts in blood may reflect disease progression and treatment effect in breast cancer. Genet Mol Res. 2010;9(1):97-106.
Basaran, G., Okkan, S., Çaglar, H., Benekli, M., Gümüş, M., Haydaroğlu , A., Eralp, Y., Abalı, H., Yıldız, F., Bese, N., Gursel, B., Guney, N., Derin, D. ”Immunohistochemically Defined T1N0 Breast Cancer SungroupsHave Different Clinical Outcomes. A Retrospective Turkish Oncology Group Study. ” Cancer Research 02/2010 69(24 supplement) 3167-3167 DOI: 10.11580008-5472 SABCS-09-3167
Can, G., Topuz, E., Derin, D., Durna, Z., Aydıner, A. ”The effect of kefir on quality of life in colorectal cancer patients. Oncol Nurs Forum. 2009 Nov;36(6):E335-42. doi: 10.1188/09.ONF.E335-E342.
Guney, N., Soydinc, H.O., Basaran, M., Bavbek, S, Derin, D., Camlica, H., Yasasever, V., Topuz, E. ”Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin’s lymphoma. Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):669-74.
Guney, N., Sayilgan, T., Derin, D., Ozcan, D. ”Primary carcinoid tumor arising in mature cystic teratoma of the ovary: a case report”. Eur J Gynaecol Oncol. 2009;30(2):223-5.
Turkish Cancer Research and Warfare Organization (XVIIth National Cancer Congress) Oncology Research Second Prize: Oguzsoydinç,H., Çamlıca, H., Duranyılmaz, D., Güney, N., Derin, D., Taş, F., Dalay, N., Yasasever, V. “The Utility of the Serum and Urine UPAR Levels in Breast Cancer”
Recommendations for Fatigue During Cancer Treatment
Fatigue can be seen as a result of anemia, endocrine changes, and respiratory distress that are induced by cancer, and can also be seen in advanced cancer patients.
Recommendations for Fatigue During Cancer Treatment
Fatigue can be seen as a result of anemia, endocrine changes, and respiratory distress that are induced by cancer, and can also be seen in advanced cancer patients.
